Close
4

Bora CDMO Bora CDMO

X

Company profile for SillaJen, Inc

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
Our core Phase III clinical trial in liver cancer, “PHOCUS”, is progressing efficiently. In fact, we are expecting to obtain the Futility Analysis result this year. This result holds great significance as the first clinical result from PHOCUS. At the same time, this analysis shall enhance the credibility and expectations of Pexa-Vec in the global market. This year, SillaJen was excited to have expanded the Clinical Depar...
Our core Phase III clinical trial in liver cancer, “PHOCUS”, is progressing efficiently. In fact, we are expecting to obtain the Futility Analysis result this year. This result holds great significance as the first clinical result from PHOCUS. At the same time, this analysis shall enhance the credibility and expectations of Pexa-Vec in the global market. This year, SillaJen was excited to have expanded the Clinical Department, which will enhance our key area of focus. In order to rise to the next level, we must expand the pipeline to other tumor types.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
SillaJen, Inc
korearepublicofnew Flag
Country
Country
South Korea
Address
Address
F, 111, Hyoyeol-ro, Buk-gu, Busan, ZIP Code : 46508
Telephone
Telephone
+82(51) 517-7550
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY